Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1950 3
1951 2
1952 1
1958 1
1963 1
1976 3
1977 2
1980 1
1981 1
1982 1
1987 1
1991 1
1994 1
1996 3
1998 1
1999 1
2000 1
2001 1
2002 2
2004 3
2006 2
2008 2
2009 4
2010 4
2011 3
2012 4
2013 3
2014 9
2015 2
2016 1
2017 2
2018 3
2019 3
2020 1
2021 4
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

77 results
Results by year
Filters applied: . Clear all
Page 1
Glutaminyl cyclase is an enzymatic modifier of the CD47- SIRPα axis and a target for cancer immunotherapy.
Logtenberg MEW, Jansen JHM, Raaben M, Toebes M, Franke K, Brandsma AM, Matlung HL, Fauster A, Gomez-Eerland R, Bakker NAM, van der Schot S, Marijt KA, Verdoes M, Haanen JBAG, van den Berg JH, Neefjes J, van den Berg TK, Brummelkamp TR, Leusen JHW, Scheeren FA, Schumacher TN. Logtenberg MEW, et al. Among authors: van den berg jh. Nat Med. 2019 Apr;25(4):612-619. doi: 10.1038/s41591-019-0356-z. Epub 2019 Mar 4. Nat Med. 2019. PMID: 30833751 Free PMC article.
Differential effects of PD-1 and CTLA-4 blockade on the melanoma-reactive CD8 T cell response.
Gangaev A, Rozeman EA, Rohaan MW, Isaeva OI, Philips D, Patiwael S, van den Berg JH, Ribas A, Schadendorf D, Schilling B, Schumacher TN, Blank CU, Haanen JBAG, Kvistborg P. Gangaev A, et al. Among authors: van den berg jh. Proc Natl Acad Sci U S A. 2021 Oct 26;118(43):e2102849118. doi: 10.1073/pnas.2102849118. Proc Natl Acad Sci U S A. 2021. PMID: 34670835 Free PMC article.
Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-up.
van den Berg JH, Heemskerk B, van Rooij N, Gomez-Eerland R, Michels S, van Zon M, de Boer R, Bakker NAM, Jorritsma-Smit A, van Buuren MM, Kvistborg P, Spits H, Schotte R, Mallo H, Karger M, van der Hage JA, Wouters MWJM, Pronk LM, Geukes Foppen MH, Blank CU, Beijnen JH, Nuijen B, Schumacher TN, Haanen JBAG. van den Berg JH, et al. J Immunother Cancer. 2020 Aug;8(2):e000848. doi: 10.1136/jitc-2020-000848. J Immunother Cancer. 2020. PMID: 32753545 Free PMC article. Clinical Trial.
Transgenerational transfer of gene-modified T cells.
Cosgrove C, Dellacecca ER, van den Berg JH, Haanen JB, Nishimura MI, Le Poole IC, Bergmans HEN. Cosgrove C, et al. Among authors: van den berg jh. J Immunother Cancer. 2019 Jul 15;7(1):186. doi: 10.1186/s40425-019-0657-2. J Immunother Cancer. 2019. PMID: 31307533 Free PMC article.
DNA vaccines and intradermal vaccination by DNA tattooing.
Oosterhuis K, van den Berg JH, Schumacher TN, Haanen JB. Oosterhuis K, et al. Among authors: van den berg jh. Curr Top Microbiol Immunol. 2012;351:221-50. doi: 10.1007/82_2010_117. Curr Top Microbiol Immunol. 2012. PMID: 21107792 Review.
Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8+ T cells.
Matas-Rico E, Frijlink E, van der Haar Àvila I, Menegakis A, van Zon M, Morris AJ, Koster J, Salgado-Polo F, de Kivit S, Lança T, Mazzocca A, Johnson Z, Haanen J, Schumacher TN, Perrakis A, Verbrugge I, van den Berg JH, Borst J, Moolenaar WH. Matas-Rico E, et al. Among authors: van den berg jh. Cell Rep. 2021 Nov 16;37(7):110013. doi: 10.1016/j.celrep.2021.110013. Cell Rep. 2021. PMID: 34788605 Free PMC article.
77 results